Overbrook Management Corp’s ImmuCell ICCC Stock Holding History

Overbrook Management Corp’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-32,857	Closed	-$159K	–	57
2024 Q2	$159K	Hold	32,857	–	–	0.04%	53
2024 Q1	$174K	Hold	32,857	–	–	0.05%	56
2023 Q4	$167K	Hold	32,857	–	–	0.03%	62
2023 Q3	$175K	Hold	32,857	–	–	0.04%	60
2023 Q2	$164K	Hold	32,857	–	–	0.04%	65
2023 Q1	$168K	Sell	32,857 -2,675	-8%	-$17.4K	0.04%	72
2022 Q4	$217K	Hold	35,532	–	–	0.06%	73
2022 Q3	$266K	Hold	35,532	–	–	0.08%	65
2022 Q2	$309K	Sell	35,532 -10,344	-23%	-$89.7K	0.09%	66
2022 Q1	$443K	Sell	45,876 -29,593	-39%	-$255K	0.1%	63
2021 Q4	$604K	Sell	75,469 -6,656	-8%	-$59.5K	0.12%	62
2021 Q3	$769K	Sell	82,125 -5,100	-6%	-$48.3K	0.17%	49
2021 Q2	$829K	Sell	87,225 -200	-0.2%	-$1.95K	0.17%	52
2021 Q1	$843K	Sell	87,425 -600	-0.7%	-$5.63K	0.19%	52
2020 Q4	$524K	Hold	88,025	–	–	0.13%	54
2020 Q3	$478K	Hold	88,025	–	–	0.11%	78
2020 Q2	$416K	Buy	+88,025	New	+$384K	0.11%	84

Other funds holding ICCC

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Overbrook Management Corp's ICCC Position: Q3 2024 in Review

Overbrook Management Corp sold out of ImmuCell (ICCC) in Q3 2024, closing a stake of 32,857 shares — an estimated $159K sold.

Overbrook Management Corp first reported a position in ICCC in Q2 2020 and held it in 17 quarters. The position peaked at $843K in Q1 2021. 22 funds tracked by Wall St. Rank hold ICCC as of Q3 2024.

Overbrook Management Corp reported no remaining ImmuCell position as of Q3 2024 after selling out during the quarter.
Overbrook Management Corp sold 32,857 ImmuCell shares in Q3 2024, an estimated $159K.
Overbrook Management Corp first reported a position in ImmuCell in Q2 2020 and held it in 17 quarters.
Overbrook Management Corp's ImmuCell position peaked at $843K in Q1 2021.
22 funds tracked by Wall St. Rank held ImmuCell as of Q3 2024.

Based on Overbrook Management Corp's 13F filing for Q3 2024, filed 8 Nov 2024.